Considering Trying Options
My First Winning Options Play: A Real-World Example from the GLP-1 Boom My First Winning Options Play: A Real-World Example from the GLP-1 Boom (And Why I Started with Established Names) Options trading can feel intimidating—especially as a beginner. The potential for big wins comes with equally big risks, including losing your entire investment in a single trade. But with the right education, thesis, and risk management, it can be a powerful way to participate in market trends. In a recent chat with Grok, I explored rotating out of pure momentum micro-caps into more established players in the health/tech/bio space, like GLP-1 leaders (Eli Lilly - LLY, Novo Nordisk - NVO) or Palantir ecosystem partners. The discussion included a step-by-step walkthrough of my hypothetical "first winning" options play: a bullish call on Eli Lilly during the 2023 GLP-1 surge. The Theme: GLP-1 Drugs and the Obesity Treatment Revolution In early 2023, GLP-1 receptor agonist...